Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Non-Injectable Insulin Sales to Surge at 9.50% CAGR by 2034, Fueled by R&D and Innovation | Future Market Insights, Inc

This image opens in the lightbox

News provided by

Future Market Insights

23 Nov, 2023, 11:55 GMT

Share this article

Share toX

Share this article

Share toX

The non-injectable insulin market is poised for significant growth, propelled by advancements in drug delivery technologies and a rising demand for convenient and patient-friendly insulin treatments. This report delves into the future of insulin therapy over the next decade, highlighting the increasing prominence of non-invasive insulin delivery methods.

NEWARK, Del., Nov. 23, 2023 /PRNewswire/ -- Oral Pills and Hospital Pharmacies Market Analysis for Non-Injectable Insulin 2024 to 2034

The non-injectable insulin market is projected to generate US$ 1372.9 million in 2024. According to projections, the market will reach US$ 4,418.70 million in 2034. Between 2023 and 2033, the market is expected to register a CAGR of 9.50%.  Pharmaceutical companies and researchers strive to offer more convenient alternatives to traditional insulin injections, the market for non-injectable insulin has seen notable growth in recent years. With products like Afrezza, inhaled insulin offers needle-free administration, so it has been gaining attention for enhancing treatment adherence.

Empower Informed Decision-Making: Preview Our Comprehensive Non-Injectable Insulin Market Research Report Before You Buy

As insulin is easy to administer, enzyme degradation may challenge its advancement, but new formulations and protective technologies are helping to address this issue. With advancements in skin permeability, transdermal insulin delivery is becoming a less invasive option. Long-term safety and efficacy are being refined for implantable insulin delivery devices.

Regulatory approvals and clinical trials of non-injectable insulin are poised to grow the market substantially, making it easier for diabetics to manage their condition. Healthcare stakeholders, who expect a significant impact on diabetes management, are closely monitoring these developments. The FDA approved a new emergency hypoglycemia treatment, Baqsimi. Individuals four years and older can receive this treatment, a powder administered through the nose. The United States has approved injectable glucagon for several decades. It was the first non-injectable glucagon product that was available.

A speaker at the World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease said there are several new ways diabetes patients could manage their condition through non-injectable insulin delivery. According to a speaker, oral insulin formulation could become a reality soon. The FDA approved Semaglutide (Rybelsus, Novo Nordisk) in September for treating type 2 diabetes without injections. Several large trials showed that this therapy reduced HbA1c significantly compared to placebo in several large trials. In addition to empagliflozin, sitagliptin, and empagliflozin, the oral SGLT2 inhibitor was demonstrated to reduce HbA1c significantly.

Non-injectable Insulin Market Research Report Coverage: 2024-2034

Attributes

Details

Estimated Market Size in 2024

US$ 1372.9 million

Projected Market Valuation in 2034

US$ 4,418.70 million

Value-based CAGR 2024 to 2034

9.50 %

Forecast Period

2024 to 2034

Historical Data Available for

2019 to 2023

Market Analysis

Value in US$ million

Key Regions Covered

North America

Latin America

Western Europe

Eastern Europe

South Asia and Pacific

East Asia

The Middle East & Africa

Key Market Segments Covered

Dosage

Distribution Channel

Region

Key Countries Profiled

The United States

Canada

Brazil

Mexico

Germany

The United Kingdom

France

Spain

Italy

Russia

Poland

Czech Republic

Romania

India

Bangladesh

Australia

New Zealand

China

Japan

South Korea

GCC countries

South Africa

Israel

Key Companies Profiled

Novo Nordisk

Sanofi

Eli Lilly

MannKind Corporation

Biocon

Janssen Pharmaceuticals

Adocia

Oramed Pharmaceuticals

Dance Biopharm

Medtronic

Verily Life Sciences

Zafgen

Dance Biopharm

Senseonics

Bigfoot Biomedical







Understand global, regional, and country-level parameters with growth opportunities, historical data (2019-2023), and forecasts (2024-2034). Buy this report today!

Key Takeaways

  • Based on dosage, oral pills are projected to hold a market share of 47% during the forecast period.
  • Hospital pharmacies are expected to account for 46% of the market in 2024.
  • The non-injectable insulin market in China is forecast to increase by 11.2% CAGR from 2024 to 2034.
  • Non-injectable insulins are projected to expand at a CAGR of 7.2% in the United States.
  • The market for non-injectable insulin in Japan is predicted to expand at a CAGR of 5.4%.

"Research and development activities in the healthcare sector have increased. A combination of new technologies and studies will increase the demand for non-injectable insulins on the market," says Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.).

Competitive Landscape

A high level of fragmentation characterizes non-injectable insulin management owing to multiple participants. Patients with diabetes have benefited from technology.

  • With modern insulin treatment solutions, managing insulin levels successfully is much easier and more efficient than traditional insulin methods. Through mergers, acquisitions, partnerships, collaborations, and product launches.
  • Industry Developments Include
  • In April 2023, Spin-off developed oral insulin and received commercial backing. Proto Axiom, an Australian biotechnology incubator, has given $2.2 million in funding to a company founded by three University of Sydney and Sydney Local Health District academics.
  • In June 2023, Dexcom announced the development of an automated continuous glucose monitoring solution aimed at the 25 million Americans without insulin-dependent type 2 diabetes. People without insulin who have type 2 diabetes will be able to use Dexcom's innovative CGM system.

Purchase this report now to get key companies with their Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis.

More Valuable Insights Available

Future Market Insights offers an unbiased global market analysis, providing historical data for 2019 to 2023 and forecast statistics from 2024 to 2034.

To understand opportunities in the non-injectable insulin market, the market is segmented based on Dosage (Oral Pills, Sprays, Others), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Drug Stores), and Region (North America, Latin America, Western Europe, Eastern Europe, South Asia and Pacific, East Asia, Middle East, and Africa).

About the Healthcare Division at Future Market Insights

The healthcare team at Future Market Insights offers expert analysis, time-efficient research, and strategic recommendations with the objective of providing authentic insights and accurate results to help clients worldwide. With a repertoire of over 100+ reports and 1 million+ data points, the team has been analyzing the industry lucidly in 50+ countries for over a decade. The team provides a brief analysis of key trends, including competitive landscape, profit margin, and research development efforts.

About the Author:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

Explore FMI's Extensive Coverage in the Healthcare Domain:

  • Postmenopausal Osteoporosis Treatment Market Analysis: Bisphosphonates, Vitamin D3, Estrogen Agonist/Antagonist, and Hormone Replacement Therapy from 2024 to 2034. - Review the report overview and request a complimentary sample report.
  • Artificial Tears Market Forecast by Dry Eye Syndrome and Infections from 2024 to 2034. - Review the report overview and request a complimentary sample report.
  • Body Slimming Device Market Analysis by Diode Laser and Radiofrequency (RF) Products, 2024 to 2034. - Review the report overview and request a complimentary sample report.
  • Analyzing Generic Oncology Drug Sales Forecast in Europe and MENA by Large and Small Molecules, 2023 to 2033. - Review the report overview and request a complimentary sample report.
  • Chemical Peel Market Analysis by Superficial, Medium, and Deep Peel Types from 2024 to 2034. - Review the report overview and request a complimentary sample report.

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai and has delivery centers in the United Kingdom, the United States, and India. FMI's latest market research reports and industry analysis helps businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition.

Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us
Nandini Singh Sawlani   
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Logo: https://mma.prnewswire.com/media/1197648/3531122/FMI_Logo.jpg 

Modal title

Also from this source

Isoprene Rubber Latex Market is Projected to Expand at a CAGR of 8.1% between 2024 and 2034 | Future Market Insights, Inc.

Isoprene Rubber Latex Market is Projected to Expand at a CAGR of 8.1% between 2024 and 2034 | Future Market Insights, Inc.

The isoprene rubber latex industry is predicted to be valued at USD 922 million by 2024. The market valuation is estimated to be USD 2,005.3 million...

Growing Demand for Premium Distilled Agave-based Beverages to Propel Mezcal Market at a CAGR of 14.2% by 2034 | Future Market Insights, Inc.

Growing Demand for Premium Distilled Agave-based Beverages to Propel Mezcal Market at a CAGR of 14.2% by 2034 | Future Market Insights, Inc.

According to Future Market Insights (FMI), the global mezcal market demand is estimated to reach a valuation of USD 635 million by 2024. Over the...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

Pharmaceuticals

Pharmaceuticals

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.